Phosphoinositide 3 kinase enhancer (PIKE) is a recently identified nuclear GTPase that activates nuclear phosphoinositide 3-kinase (PI3 kinase). We have identified, cloned and characterized a new form ...
Biomarker-driven access to vemurafenib in BRAF-positive cancers: Second study of the French National AcSé Program. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
Oral PI3 kinase inhibitor BKM120 monotherapy in patients (pts) with advanced solid tumors: An update on safety and efficacy. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This ...
Prostate cancer remains the second leading cause of cancer mortality among American males. The predominant reason for such high and persistent mortality is the lack of curative therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results